These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30551118)

  • 1. MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.
    Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
    Biomed Pharmacother; 2019 Feb; 110():656-666. PubMed ID: 30551118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
    Pan X; Quan J; Li Z; Zhao L; Zhou L; Jinling X; Weijie X; Guan X; Li H; Yang S; Gui Y; Lai Y
    Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1).
    Li Y; Quan J; Chen F; Pan X; Zhuang C; Xiong T; Zhuang C; Li J; Huang X; Ye J; Zhang F; Zhang Z; Gui Y
    Biomed Pharmacother; 2019 Mar; 111():517-526. PubMed ID: 30597305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
    Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y
    Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer.
    Liu S; Wang Y; Li W; Yu S; Wen Z; Chen Z; Lin F
    Biomed Pharmacother; 2019 Nov; 119():109406. PubMed ID: 31514066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic miR-663a is associated with cellular function and poor prognosis in renal cell carcinoma.
    Zhou L; Pan X; Li Z; Chen P; Quan J; Lin C; Lai Y; Xu J; Xu W; Guan X; Li H; Gui Y; Lai Y
    Biomed Pharmacother; 2018 Sep; 105():1155-1163. PubMed ID: 30021352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
    Pan X; Li Z; Zhao L; Quan J; Zhou L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y
    Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.
    Chen X; Ruan A; Wang X; Han W; Wang R; Lou N; Ruan H; Qiu B; Yang H; Zhang X
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1295-304. PubMed ID: 24802708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
    Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
    J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma.
    Sun C; Sun C; Zhou Y; Yang G; Li G; Xiang C; Ding X; Sun J
    Mol Med Rep; 2019 Dec; 20(6):5208-5215. PubMed ID: 31661131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA EGLN3 silencing represses renal cell carcinoma progression through the miR-1224-3p/HMGXB3 axis.
    Zhang G; Wang J; Tan W; Han X; Han B; Wang H; Xia Y; Sun Y; Li H
    Acta Histochem; 2021 Sep; 123(6):151752. PubMed ID: 34274607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma.
    Mao W; Wang K; Xu B; Zhang H; Sun S; Hu Q; Zhang L; Liu C; Chen S; Wu J; Chen M; Li W; Peng B
    Mol Cancer; 2021 Nov; 20(1):142. PubMed ID: 34740354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-378a-3p promotes renal cell carcinoma proliferation, migration, and invasion by targeting TOB2.
    Bao N; Zhang P; Zhu Y; Du P; Jin G; Wu B; Ding T
    Clin Transl Oncol; 2023 Mar; 25(3):748-757. PubMed ID: 36309620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
    Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
    Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.
    Redova M; Poprach A; Besse A; Iliev R; Nekvindova J; Lakomy R; Radova L; Svoboda M; Dolezel J; Vyzula R; Slaby O
    Tumour Biol; 2013 Feb; 34(1):481-91. PubMed ID: 23150176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0000274 contributes to renal cell carcinoma progression by regulating miR-338-3p/NUCB2 axis and JAK1/STAT3 pathway.
    Qi Q; Sun Y; Yang Y; Liu Y
    Transpl Immunol; 2022 Oct; 74():101626. PubMed ID: 35569717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-206 inhibits renal cell cancer growth by targeting GAK.
    Wei C; Wang S; Ye ZQ; Chen ZQ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):852-858. PubMed ID: 27924503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
    Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
    Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of lncRNA MEG8 Represses the Viability, Migration, and Invasion of Wilms' Tumor Cells through Mediating miR-23a-3p/CRK Axis.
    Shen J; Shu Q
    Urol Int; 2022; 106(10):1075-1087. PubMed ID: 34518485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.